Is iBio, Inc. (IBIO) a Buy, Sell, or Hold?
NASDAQ : IBIO
iBio, Inc. — Institutional Ownership
$1.41 USD
$0.02 (1.44%)
- Volume
- 435.93K
- Average Volume
- 960.55K
- Market Capitalization
- $22.26M
- P/E Ratio
- -2.45
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $3.82
- Year Low
- $0.57
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $11.88
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | EcoR1 Capital, LLC | 1.58M | 4.60% |
| 2026-05-15 | Cormorant Asset Management, LP | 3.83M | 9.99% |
| 2026-05-15 | Logos Global Management LP | - | 0.00% |
| 2026-05-15 | Point72 Asset Management, L.P. | - | 0.00% |
| 2026-05-15 | Sirenia Capital Management LP | 11.59M | 9.90% |
| 2026-05-14 | Affinity Asset Advisors, LLC | 3.49M | 9.99% |
| 2026-05-12 | Frazier Life Sciences Public Fund, L.P. | 1.95M | 5.70% |
| 2026-02-17 | ADAR1 Capital Management, LLC | 1.35M | 4.40% |
| 2026-02-17 | Lynx1 Capital Management LP | - | 0.00% |
| 2026-02-17 | Logos Global Management LP | 1.5M | 4.60% |
| 2026-01-29 | Affinity Asset Advisors, LLC | 2.4M | 9.99% |
| 2026-01-22 | Integrated Core Strategies (US) LLC | 1.23M | 5.20% |
| 2025-12-19 | Logos Global Management LP | 2M | 8.90% |
| 2025-12-17 | EcoR1 Capital, LLC | 2.23M | 9.90% |
| 2025-12-16 | Frazier Life Sciences Public Fund, L.P. | 1.95M | 8.70% |
| 2025-12-03 | Affinity Asset Advisors, LLC | 2.18M | 9.99% |
| 2025-11-14 | SilverArc Capital Management, LLC | 2.18M | 9.99% |
| 2025-11-14 | Vestal Point Capital, LP | 4.28M | 9.90% |
| 2025-11-14 | Ikarian Capital, LLC | 1.15M | 4.99% |
| 2025-11-14 | Cormorant Asset Management, LP | 2.25M | 9.99% |
| 2025-11-13 | Adage Capital Management, L.P. | 2.18M | 9.99% |
| 2025-08-26 | Affinity Healthcare Fund, LP | 4.28M | 9.99% |
| 2025-08-25 | Point72 Asset Management, L.P. | 14.29M | 9.90% |
| 2025-08-14 | ADAR1 Capital Management, LLC | 1.79M | 9.90% |
| 2025-07-30 | Patrick J. Crutcher | 847.04K | 3.10% |
| 2025-02-14 | Opaleye Management, Inc. | 750K | 7.60% |
| 2025-02-14 | ADAR1 Capital Management, LLC | 1.1M | 9.99% |
| 2025-01-30 | Patrick J. Crutcher | 696.71K | 7.00% |
| 2025-01-29 | Patrick J. Crutcher | 714.71K | 7.20% |
| 2025-01-03 | SABBY MANAGEMENT, LLC | 19250.0 | 0.20% |
| 2024-11-14 | Ikarian Capital, LLC | 599.91K | 6.60% |
| 2024-11-14 | Neil Shahrestani | 599.91K | 6.60% |
| 2024-04-05 | ADAR1 Capital Management GP, LLC | 789.29K | 9.27% |
| 2024-04-05 | ADAR1 Capital Management, LLC | 789.29K | 9.27% |
| 2024-04-05 | ADAR1 Partners, LP | 789.29K | 9.27% |
| 2024-04-05 | Daniel Schneeberger | 789.29K | 9.27% |
| 2024-04-01 | Weston Nichols | 878.49K | 9.99% |
| 2024-04-01 | Lynx1 Capital Management LP | 878.49K | 9.99% |
| 2023-02-09 | The Vanguard Group - 23-1945930 | 475.59K | 5.28% |
| 2022-07-08 | (1) BlackRock, Inc. | 3.96M | 1.80% |
| 2022-02-03 | (1) BlackRock, Inc. | 15.48M | 7.10% |
| 2021-02-02 | (1) BlackRock, Inc. | 11.58M | 5.50% |
| 2020-08-11 | SCHEDULE 13D/A | 12.0 | 14.00% |
| 2013-06-13 | E. Gerald Kay | 5.95M | 10.49% |
| 2013-06-13 | CD Financial, LLC | 1.53M | 2.70% |
| 2013-06-13 | EGK, LLC | 778.73K | 1.37% |
| 2013-06-13 | DeSantis Revocable Trust | 2.24M | 3.94% |
| 2013-06-13 | Carl DeSantis | 5.04M | 8.89% |
| 2008-08-21 | E. Gerald Kay | 6.39M | 27.23% |
| 2008-08-21 | Robert B. Kay | 2.3M | 9.80% |
| 2008-08-21 | EVJ, LLC | 819.63K | 3.49% |
| 2008-08-21 | Integrated BioPharma, Inc. | 1.27M | 5.40% |
| 2008-08-21 | Carl DeSantis | 4.92M | 20.98% |
| 2008-08-21 | CDS Group Holdings, LLC | 819.63K | 3.49% |
| 2008-08-21 | Riva Kay Sheppard | 2.47M | 10.52% |
| 2008-08-21 | CD Financial, LLC | 1.41M | 6.00% |
| 2008-08-21 | Christina Kay | 2.47M | 10.52% |
| 2008-08-21 | EGK, LLC | 819.63K | 3.49% |
IBIO Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-06-30 | $0.76 | 10.5M | $8.01M | $8.58M | $3.51M | $2.94M |
| 2024-06-30 | $2.01 | 3.83M | $7.7M | $14.21M | $4.46M | -$2.05M |
| 2023-06-30 | $12.20 | 612.25K | $7.47M | $7.33M | $17.07M | $17.22M |
| 2022-06-30 | $130.00 | 17442 | $2.27M | $22.68M | $25.77M | $5.36M |
| 2021-06-30 | $755.00 | 391.24K | $295.39M | $77.4M | $32.72M | $250.7M |
| 2020-06-30 | $1110.00 | 125.59K | $139.4M | $55.11M | $32.91M | $117.2M |
| 2019-06-30 | $350.00 | 37852 | $13.25M | $4.42M | $24.88M | $33.71M |
| 2018-06-30 | $450.00 | 21262 | $9.57M | $15.93M | $25.08M | $18.71M |
| 2017-06-30 | $1950.00 | 17822 | $34.75M | $8.09M | $25.26M | $51.93M |
| 2016-06-30 | $3600.00 | 16194 | $58.3M | $23.01M | $25.44M | $60.72M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1.90 | 119.6M | $227.24M | $47.63M | $2.32M | $181.93M |
| 2025-12-31 | $1.93 | 99.13M | $191.33M | $28.67M | $2.45M | $165.1M |
| 2025-09-30 | $0.83 | 52.98M | $43.86M | $28.11M | $3.29M | $19.04M |
| 2025-06-30 | $0.76 | 16.42M | $12.53M | $8.58M | $3.51M | $7.46M |
| 2025-03-31 | $4.02 | 9.86M | $39.65M | $4.96M | $3.76M | $38.44M |
| 2024-12-31 | $2.45 | 9.13M | $22.37M | $7.02M | $4M | $19.36M |
| 2024-09-30 | $2.22 | 8.63M | $19.17M | $11.04M | $4.23M | $12.36M |
| 2024-06-30 | $2.01 | 8.62M | $17.33M | $14.21M | $4.46M | $7.58M |
| 2024-03-31 | $3.35 | 3.71M | $12.44M | $5.3M | $17.33M | $24.47M |
| 2023-12-31 | $1.37 | 1.86M | $2.54M | $2.79M | $17.27M | $17.03M |
| 2023-09-30 | $6.00 | 1.2M | $7.19M | $1.46M | $16.96M | $22.69M |
| 2023-06-30 | $12.20 | 1.02M | $12.39M | $7.33M | $17.07M | $22.14M |